WO2014011926A1 - Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk - Google Patents

Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk Download PDF

Info

Publication number
WO2014011926A1
WO2014011926A1 PCT/US2013/050142 US2013050142W WO2014011926A1 WO 2014011926 A1 WO2014011926 A1 WO 2014011926A1 US 2013050142 W US2013050142 W US 2013050142W WO 2014011926 A1 WO2014011926 A1 WO 2014011926A1
Authority
WO
WIPO (PCT)
Prior art keywords
metformin
mg
wo
release
dosage form
Prior art date
Application number
PCT/US2013/050142
Other languages
French (fr)
Inventor
Alain D. Baron
Mark S. Fineman
Nigel R. A. Beeley
Original Assignee
Elcelyx Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US13/547,022 priority Critical
Priority to US13/547,022 priority patent/US8796338B2/en
Priority to US13/734,966 priority
Priority to US13/734,966 priority patent/US9211263B2/en
Application filed by Elcelyx Therapeutics, Inc. filed Critical Elcelyx Therapeutics, Inc.
Priority claimed from US14/414,091 external-priority patent/US9572784B2/en
Publication of WO2014011926A1 publication Critical patent/WO2014011926A1/en

Links